{"DataElement":{"publicId":"14746922","version":"1","preferredName":"Pathologic Diagnosis Assessed Finding Type","preferredDefinition":"The text term that describes the pathologic diagnosis assessment finding.","longName":"PATH_DIAG_FNDG","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2188929","version":"1","preferredName":"Pathologic Diagnosis Assessed","preferredDefinition":"information related to an assessed pathologic diagnosis.","longName":"PATH_DX_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206613","version":"1","preferredName":"Pathologic Diagnosis","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:The process of identifying a disease by the signs and symptoms.","longName":"C25610:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FC5F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177636","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"Assessed","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5183-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C8A3AA-CB2B-1DDB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14746909","version":"1","preferredName":"Pathological Diagnosis Finding Type","preferredDefinition":"Diagnosis based on a pathological assessment._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Something distinguishable as an identifiable class based on common qualities.","longName":"14746909v1.00","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Atypical hyperplasia/CAH/EIN","valueDescription":null,"ValueMeaning":{"publicId":"14746911","version":"1","preferredName":"Atypical Hyperplasia Or Congenital Adrenal Hyperplasia Or Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia","longName":"14746911v1.00","preferredDefinition":"A benign (noncancerous) condition in which tissue has certain abnormal features._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A genetic disorder characterized by defects in the synthesis of cortisol and/or aldosterone, resulting in hyperplasia of the adrenal cortical cells._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Hyperplasia","conceptCode":"C8355","definition":"A benign (noncancerous) condition in which tissue has certain abnormal features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Congenital Adrenal Hyperplasia","conceptCode":"C34360","definition":"A genetic disorder characterized by defects in the synthesis of cortisol and/or aldosterone, resulting in hyperplasia of the adrenal cortical cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia","conceptCode":"C27789","definition":"A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4ECC8-260F-360A-E063-731AD00AA080","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2614-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"Benign endometrium (no hyperplasia/malignancy)","valueDescription":null,"ValueMeaning":{"publicId":"14746913","version":"1","preferredName":"Benign Endometrial Neoplasm","longName":"14746913v1.00","preferredDefinition":"A neoplastic endometrial proliferation that is confined to the endometrium and does not have metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Endometrial Neoplasm","conceptCode":"C4894","definition":"A neoplastic endometrial proliferation that is confined to the endometrium and does not have metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4ECC8-2611-360A-E063-731AD00AA080","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2615-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"Non-atypical hyperplasia","valueDescription":null,"ValueMeaning":{"publicId":"14746914","version":"1","preferredName":"Negation Atypical Hyperplasia","longName":"14746914v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._A benign (noncancerous) condition in which tissue has certain abnormal features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Atypical Hyperplasia","conceptCode":"C8355","definition":"A benign (noncancerous) condition in which tissue has certain abnormal features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4ECC8-2612-360A-E063-731AD00AA080","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2616-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"Atypical hyperplasia/EIN","valueDescription":null,"ValueMeaning":{"publicId":"14746915","version":"1","preferredName":"Atypical Hyperplasia Or Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia","longName":"14746915v1.00","preferredDefinition":"A benign (noncancerous) condition in which tissue has certain abnormal features._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Hyperplasia","conceptCode":"C8355","definition":"A benign (noncancerous) condition in which tissue has certain abnormal features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia","conceptCode":"C27789","definition":"A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4ECC8-2613-360A-E063-731AD00AA080","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2617-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"Endometrial cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581346","version":"1","preferredName":"Endometrial Carcinoma","longName":"5581346","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B92E-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2618-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"N/A (no hysterectomy)","valueDescription":null,"ValueMeaning":{"publicId":"7590024","version":"1","preferredName":"Not Applicable","longName":"7590024","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCB96B6E-DDC3-6924-E053-4EBD850AEF18","latestVersionIndicator":"Yes","beginDate":"2021-03-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2021-03-04","modifiedBy":"KUMMEROA","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":"7/8/22 added alt name of NA for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-2619-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"EIN bordering on/suspicious for endometrial cancer","valueDescription":null,"ValueMeaning":{"publicId":"14746912","version":"1","preferredName":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia Borderline Or Suspicious Endometrial Carcinoma","longName":"14746912v1.00","preferredDefinition":"A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations._Straddling the dividing line between two categories._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Of a questionable or potentially dangerous nature._A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia","conceptCode":"C27789","definition":"A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Borderline","conceptCode":"C14157","definition":"Straddling the dividing line between two categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Suspicious","conceptCode":"C131271","definition":"Of a questionable or potentially dangerous nature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4ECC8-2610-360A-E063-731AD00AA080","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E4ECC8-261A-360A-E063-731AD00AA080","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14746908","version":"1","preferredName":"Pathological Diagnosis Finding Type","preferredDefinition":"Diagnosis based on a pathological assessment._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Something distinguishable as an identifiable class based on common qualities.","longName":"14746908v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathological Diagnosis","conceptCode":"C178004","definition":"Diagnosis based on a pathological assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4564A-6ED1-0FE1-E063-731AD00AD152","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E4564A-6ED2-0FE1-E063-731AD00AD152","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"2/8/2024: Created VD(CADSR0003370)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Pathologic diagnosis finding","url":null,"context":"DCP"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Pre-Treatment Biopsy Pathologic Diagnosis","url":null,"context":"DCP"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Post-Treatment Hysterectomy Pathologic Diagnosis","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E5380E-4415-467E-E063-731AD00A735F","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-08","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"2/8/2024: Created CDE(CADSR0003370)-MM","unresolvedIssues":null,"deletedIndicator":"No"}}